Omega-3 polyunsaturated fatty acids

Omega-3 polyunsaturated fatty acids has been studied in 74 papers since 2012: 11 trials and 14 observational studies in people, 5 in animals, 42 reviews; 20 in the past year. The newest paper, Nov 12, 2026: “Marine Products and Age-Related Diseases: The Path from Pre-Clinical Research to Regulatory Approval for thpe Treatment of Neurodegenerative and Musculoskeletal Diseases”.

Intervention

74 papers study it88 findingsUpdated

Research on it is growing 68% faster than aging research as a whole: 12 papers in the latest year counted

More supplements

3 new papers in 30 daysSee all 74 papers on omega-3 polyunsaturated fatty acids

At a glance

Omega-3 polyunsaturated fatty acids are linked with less unhealthy aging in a human cohort; a trial shows no clear slowing of cognitive decline in older adults with memory complaints. One group reports the human results. Papers report company ties; most registered trials across uses have developer sponsors, and some ended over a year ago without posted results.

88 findings in 46 papers from 2012 to 2026, 6 of them since April 2026

The findings reach people, from one lab or study. 29 independent labs in 19 countries; 21 trials, 10 about aging, 3 with no results posted.

“The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints”
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trialThe Lancet. Neurology2017doi:10.1016/s1474-4422(17)30040-6

3 of its findings point the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 29 independent labs in 19 countries
  • 3 findings against
  • 21 trials, 10 about aging, 3 with no results posted
  • Funders: National Institutes of Health and others
  • 5 of 60 findings with company ties
  • 14 of 21 trials sponsored by its developers
  • Human trial11
  • Humans14
  • Animals5

10 studies gave omega-3 polyunsaturated fatty acids to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on functional recovery

no change: Has no effect on creatine kinase and inflammatory markers

Randomized trial8 weeks43 peopleBoth65–85 yearsOlder adults; after eccentric-emphasized leg extensionsAge and ageing, Oct 31, 2026

down: Decreases brain entropy

Randomized trial52-week20 peopleolder adultsOlder adults; Patient cohortsJournal of affective disorders, Jan 26, 2024

up: Increases erythrocyte membrane EPA and DHA content

down: Decreases inflammation mediators

down: Decreases cardiac damage markers

Randomized trialthree weeks24 peopleMen3 weeks of supplementation compared with baselineJournal of human kinetics, Oct 27, 2023

up: Improves muscle strength

down: Decreases exercise responsiveness

Randomized trial6 months65 people29 male/34 female71.4 ± 4.6 yearsIndependently living adults without a known chronic debilitating diseaseNutrients, Aug 27, 2022

no change: Has no effect on appendicular lean mass

down: Impairs isometric knee flexion peak torqued = −0.43

down: Decreases triacylglycerols

Randomized trial24-wk107 peopleBoth≥65 y of ageUrban community-dwelling men and womenThe American journal of clinical nutrition, Apr 20, 2021

What did studies of omega-3 polyunsaturated fatty acids find?

63

Studies of omega-3 polyunsaturated fatty acids measured 63 outcomes; the most studied are inflammation (3 studies), muscle strength (2) and muscle protein synthesis (2).

Inflammation

downin reviews2downin humans1

3 studies
  1. Omega-3 polyunsaturated fatty acids decrease inflammation.

    Review

  2. Omega-3 polyunsaturated fatty acids decrease inflammation in humans.

    Review

  3. Omega-3 polyunsaturated fatty acids inhibit inflammation.

    Reviewmuscle

More on Inflammation

Muscle strength

upin humans2

2 studies
  1. Omega-3 polyunsaturated fatty acids improve muscle strength in humans.

    Human trial6 monthsn = 65

  2. Omega-3 polyunsaturated fatty acids improve muscle strength in humans (healthy older adults) (3.1 ± 14.7% increase in placebo vs. 7.5 ± 14.1% increase in n3-PUFA; p = 0.039).

    Human trialhealthy older adults4 g/day6 monthsn = 30

  3. Omega-3 polyunsaturated fatty acids increase muscle strength in humans (combined with resistance exercise training).

    Reviewcombined with resistance exercise trainingwomens

muscle protein synthesis

upin humans1upin reviews1

2 studies
  1. Omega-3 polyunsaturated fatty acids increase muscle protein synthesis (via the mTOR pathway).

    Reviewvia the mTOR pathwaymuscle

  2. Omega-3 polyunsaturated fatty acids increase muscle protein synthesis in humans (sedentary).

    Reviewsedentaryfish oil-derivedskeletal muscle

Muscle function

upin humans2

2 studies
  1. Omega-3 polyunsaturated fatty acids improve muscle function in humans.

    Review

  2. Omega-3 polyunsaturated fatty acids improve muscle function in humans (sedentary).

    Reviewsedentaryfish oil-derivedskeletal muscle

Time-to-first major cardiovascular event or all-cause death

downin humans1no changein humans1HR 0.71–0.77

1 study
  1. Omega-3 polyunsaturated fatty acids decrease time-to-first major cardiovascular event or all-cause death in humans (maintenance hemodialysis; fixed-effect high-dose subgroup analysis of PISCES and FISH) (HR 0.71, 95% CI 0.60–0.85).

    Reviewmaintenance hemodialysis; fixed-effect high-dose subgroup analysis of PISCES and FISH4 g/day

  2. Omega-3 polyunsaturated fatty acids showed no clear effect on time-to-first major cardiovascular event or all-cause death in humans (maintenance hemodialysis; pooled analysis of three trials) (HR 0.77, 95% CI 0.55–1.09; I2=60%).

    Reviewmaintenance hemodialysis; pooled analysis of three trialsn = 1,635

Isometric knee flexion peak torque

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids impair isometric knee flexion peak torque in combination with leucine-enriched protein (d = −0.43).

    Human trialin combination with leucine-enriched protein24-wkn = 107

  2. Omega-3 polyunsaturated fatty acids impair isometric knee flexion peak torque in humans (combined with leucine-enriched protein) (-7.1 Nm; 95% CI: -12.5, -1.8 Nm; P < 0.01).

    Human trialcombined with leucine-enriched protein24 wk

FSTL1

no changein humans1upin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids showed no clear effect on FSTL1 in humans (between-group comparison after intervention).

    Human trialbetween-group comparison after intervention1,200 mg daily8 weeksmales

  2. Omega-3 polyunsaturated fatty acids increase FSTL1 in humans within-group change in the omega-3 group (+27.6% within omega-3 group).

    Human trialwithin-group change in the omega-3 group1,200 mg daily8 weeksmales

More on FSTL1

Creatine kinase and inflammatory markers

no changein humans1

1 study
  1. Omega-3 polyunsaturated fatty acids showed no clear effect on creatine kinase and inflammatory markers in humans after eccentric-emphasized leg extensions; compared with placebo.

    Human trialafter eccentric-emphasized leg extensions; compared with placeboalgae oil5 mL oil containing 2 g PUFA8 weeksn = 43

More on Creatine kinase and inflammatory markers

Functional recovery

no changein humans1

1 study
  1. Omega-3 polyunsaturated fatty acids showed no clear effect on functional recovery in humans after eccentric-emphasized leg extensions.

    Human trialafter eccentric-emphasized leg extensionsalgae oilquadriceps muscle5 mL oil containing 2 g PUFA8 weeksn = 43

Recurrent major cardiovascular events

downin humans1HR 0.57

1 study
  1. Omega-3 polyunsaturated fatty acids decrease recurrent major cardiovascular events in humans (maintenance hemodialysis; PISCES trial) (HR 0.57, 95% CI 0.47–0.70; P<0.001).

    Reviewmaintenance hemodialysis; PISCES trial4 g/daymedian follow-up 3.5 yearsn = 1,228

Brain entropy

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids decrease brain entropy in humans.

    Human trialbrain52-weekn = 20

More on Brain entropy

Blood lipid profiles

upin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids improve blood lipid profiles in humans (supplemented runners).

    Human trialsupplemented runners3,000 mg dailythree weeksmales

More on Blood lipid profiles

Cardiac damage markers

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids decrease cardiac damage markers in humans (compared with placebo group).

    Human trialcompared with placebo group3,000 mg dailythree weeksmales

More on Cardiac damage markers

Inflammation mediators

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids decrease inflammation mediators in humans (measured after downhill running (eccentric exercise)).

    Human trialmeasured after downhill running (eccentric exercise)3,000 mg dailythree weeksmales

More on Inflammation mediators

Erythrocyte membrane EPA and DHA content

upin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids increase erythrocyte membrane EPA and DHA content in humans (3 weeks of supplementation compared with baseline).

    Human trial3 weeks of supplementation compared with baselineerythrocyte3,000 mg dailythree weeksmales

More on Erythrocyte membrane EPA and DHA content

All 63

What is omega-3 polyunsaturated fatty acids linked with?

14

Studies link omega-3 polyunsaturated fatty acids with 14 measures, among them Alzheimer's disease, cognitive function and lipid profile parameters.

Alzheimer's disease

downin humans1downin reviews1

2 studies
  1. Omega-3 polyunsaturated fatty acids are associated with Alzheimer's disease in humans.

    Reviewhigher levels

  2. Omega-3 polyunsaturated fatty acids lower the risk of Alzheimer's disease.

    Review

More on Alzheimer's disease

Cognitive function

no changein humans1upin humans1

2 studies
  1. Omega-3 polyunsaturated fatty acids are associated with cognitive function in humans (minor alleles at 22 identified SNPs).

    Humansminor alleles at 22 identified SNPserythrocyten = 1,620

  2. Omega-3 polyunsaturated fatty acids are associated with cognitive function in humans.

    Reviewhigher levels

Lipid profile parameters

mixedin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with lipid profile parameters in humans (patients with cardiovascular diseases).

    Human trialpatients with cardiovascular diseasesdietary therapy enriched with various sources300 to 3000 mg per day

More on Lipid profile parameters

Lung cancer

downin humans1OR 0.82

1 study
  1. Omega-3 polyunsaturated fatty acids are linked with a lower risk of lung cancer in humans (OR 0.82, 95% CI 0.70-0.96).

    Humans1 g/day

More on Lung cancer

Cardiovascular health

upin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with cardiovascular health in humans.

    Reviewhigher levels

Temporal lobe volume

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with temporal lobe volume in humans (Alzheimer's disease) (β = - 0.31, p = 0.021).

    HumansAlzheimer's diseasetemporal lobe

More on Temporal lobe volume

Depression

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with depression in humans.

    Review

More on Depression

Allostatic load-related disease risk

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with allostatic load-related disease risk in humans.

    HumansHigher intake

Bone health

mixedin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with bone health in humans.

    Review

Biological-age acceleration

downin humans1

1 study
  1. Omega-3 polyunsaturated fatty acids are associated with biological-age acceleration in humans (β -0.18, 95% CI -0.27, -0.08, P < 0.05).

    Humansn = 26,381

More on Biological-age acceleration

All 14

Has omega-3 polyunsaturated fatty acids been tested in people?

10 of 21 about aging

Yes: 11 trials and 14 observational studies in people have been published.

Funding

1 grant since 2016

Japan Society for the Promotion of Science¥3M

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 3Mar 2026: 3Apr 2026: 2May 2026: 2Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 3Oct 2026: 3Nov 2026: 120 papers in 12 months

See all 74 papers on omega-3 polyunsaturated fatty acids